Background: Improved life expectancy in high HIV prevalence populations has been
observed since antiretroviral therapy (ART) scale-up. However, it is unclear if the benefits …

BACKGROUND Recent evidence from health and demographic surveillance sites (HDSS)
has shown that increasing access to antiretroviral therapy (ART) is reducing mortality rates …

Background Antiretroviral therapy (ART) substantially decreases morbidity and mortality in
people living with HIV. In this study, we describe population-level trends in the adult life …

Objective To investigate trends in all‐cause adult mortality after the roll‐out of an
antiretroviral therapy (ART) programme in rural Uganda. Methods Longitudinal population …

Objective: To estimate the impact of antiretroviral therapy (ART) on population-wide adult life
expectancy. Study design: A population-based open cohort study with repeated HIV status …

Background: The rollout of antiretroviral therapy (ART) is one of the largest public health
interventions in Eastern and Southern Africa of recent years. Its impact is well described in …

There are limited data on the impact of antiretroviral therapy (ART) on population-level adult
mortality in sub-Saharan Africa. We analysed data for 2000–14 from the Rakai Community …

Background Rwanda has achieved substantial progress in scaling up of antiretroviral
therapy. We aimed to assess the effect of increased access to antiretroviral therapy on life …

Background Substantial falls in the mortality of people living with HIV (PLWH) have been
observed since the introduction of antiretroviral therapy (ART) in sub-Saharan Africa …

Background: Previous studies have reported improvements in life expectancies of patients
on antiretroviral treatment (ART) over time, but it is not clear whether these improvements …